Substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines - a promising class of lipoxygenase inhibitors

Authors

  • V. V. Stavytskyi Zaporizhzhia State Medical University, Ukraine,
  • I. S. Nosulenko Zaporizhzhia State Medical University, Ukraine,
  • O. O. Portna Zaporizhzhia State Medical University, Ukraine,
  • V. M. Shvets Zaporizhzhia State Medical University, Ukraine,
  • O. Yu. Voskoboynik Zaporizhzhia State Medical University, Ukraine,
  • S. І. Kоvalenko Zaporizhzhia State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2019.3.198086

Keywords:

drug discovery, pyrrolo[1, 2-a][1, 2, 4]triazolo-(triazino-)[c]quinazolines, molecular docking, lipoxygenase activity

Abstract

 

The modern strategy of potential biologically active molecules search (“drug-design”) is based on several innovation approaches. The method of high thrоughрut biological screening and method of molecular modeling deserves the most attention among such approaches. Lipoxygenase (LOX) is one owf the most perspective biological target for the substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines. So, molecular docking towards LOX and enzyme activating activity was investigated.

The aim: Directed search of potential inhibitors of lipoxygenases among the unknown pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines with the use of molecular docking and in vitro high throughput screening.

Materials and methods. The research of lipoxygenase activity has been conducted for a number of original pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines. Standard software was used for molecular docking and “drug-like” criteria research. Sodium letinate was used as a substrate to study soybean LOX enzyme activating activity.

Results. The results of molecular docking have shown, that substituted pyrrolo[1,2-a][1,2,4]triazolo[1,5-c]quinazolines reveal a strong affinity toward LOX. The main types of interactions with aminoacid residues of mentioned the enzyme were identified. The conducted researches showed, that the substituted pyrrolo[1,2-a][1,2,4]triazino[2,3-c]quinazolines had the highest soybean LOX inhibition activity. Compounds with a fluorine atom and a 2-thienyl moiety in the structure revealed the highest activity inhibiting lipoxygenase by 36.33 % and 39.83 % respectively. The increased lipophilicity of triazine derivatives promotes a higher ability to inhibit soybean LOX, whereas, for triazole derivatives, which have lower molecular weight, an inverse relation is observed.

Conclusions. The research of the substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines inhibition ability of soybean LOX as one of the possible mechanisms of their activity is proved and conducted. It is shown, that their lipoxygenase activity depends on lipophilicity and is defined by the availability of donor-acceptor fragments in the molecule, that is capable to form hydrogen and other types of interaction. The specified results are strong arguments for their further study as promising anti-inflammatory agents.

 

References

Krogsgaard-Larsen, P., Liljefors, T., & Madsen, U. (2002). Textbook of Drug Design and Discovery (3rd ed.). Washington, DC: Taylor & Francis.

Keseru, G. M., & Makara, G. M. (2009, Mar). The influence of lead discovery strategies on the properties of drug candidates. Nature Reviews Drug Discovery, 8(3), 203-212. https://doi.org/10.1038/nrd2796

Hajduk, P. J., & Greer, J. (2007). A decade of fragment-based drug design: strategic advances and lessons learned. Nature Reviews Drug Discovery, 6(3), 211-219. https://doi.org/10.1038/nrd2220

Landry, Y., & Gies, J. P. (2008). Drugs and their molecular targets: an updated overview. Fundamental & Clinical Pharmacology, 22(1), 1-18. https://doi.org/10.1111/j.1472-8206.2007.00548.x

Jung, H. J., & Kwon, H. J. (2015). Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery. Archives of Pharmacal Research, 38(9), 1627-1641. https://doi.org/10.1007/s12272-015-0618-3

Lee, H., & Lee, J. W. (2016). Target identification for biologically active small molecules using chemical biology approaches. Archives of Pharmacal Research, 39(9), 1193-1201. https://doi.org/10.1007/s12272-016-0791-z

Yakubovska, V. V., Seredinska, N. М., Voskoboynik, О. Yu., Stepanyuk, G. І., & Kovalenko, S. І. (2016). Spriamovanyi poshuk i kharakterystyka protyzapalnoi aktyvnosti natrii (3-R-2-okso-2H-[1,2,4]triazino[2,3-c]khinazolin-6-il)alkilkarboksylativ ta yikh halohenovmisnykh analohiv [Purposeful search and characteristic of anti-inflammatory activity of sodium (3-R-2-оxo-2Н-[1,2,4]triazino[2,3-c]quinazolin-6-yl)alkylcarboxylates and their halogen containing analogues]. Current issues in pharmacy and medicine: science and practice, (1), 60-66. [in Ukrainian]. https://doi.org/10.14739/2409-2932.2016.1.62036

Voskoboynik, O. Yu., Starosyla, S. A., Protopopov, M. V., Volynets, H. P., Shyshkina, S. V., Yarmoliuk, S. M., & Kovalenko, S. I. (2016). Synthesis, anticancer and FGFR1 inhibitory activity of isoindolo[2,1-a][1,2,4]triazino[2,3-c]quinazoline derivatives. Medychna ta klinichna khimiia, 18(1), 5-18. https://doi.org/10.11603/mcch.2410-681X.2016.v0.i1.6123

Voskoboynik O. Yu., Кovalenko S. I., & Shishkina S. V. (2016). 3-R1-8-R2-10-R3-2H-benzo[e][1,2,4]triazino[2,3-c][1,2,3]triazin-2-ones – novel high electro-deficient heterocyclic compounds with promising anticancer activity. Heterocyclic Communications, 22(3), 137-141. https://doi.org/10.1515/hc-2015-0190

Antypenko, O. M., Kovalenko, S. I., Karpenko, O. V., Nikitin, V. O., & Antypenko, L. M. (2016). Synthesis, Anticancer, and QSAR Studies of 2-Alkyl(aryl,hetaryl)quinazolin-4(3H)-thione's and 1,2,4 Triazolo 1,5-c quinazoline-2-thione's Thioderivatives. Helvetica Chimica Acta, 99(8), 621-631. https://doi.org/10.1002/hlca.201600062

Antypenko, O. M., Kovalenko, S. I., Rasulev, B. F., & Leszczynsk, J. (2016). Synthesis of 6-N-R-tetrazolo[1,5-c]quinazolin-5(6H)-ones, anticancer activity and QSAR modeling. Acta Chimica Slovenica, 63(3), 638-645. https://doi.org/10.17344/acsi.2016.2464

Kolomoets, O. S., Voskoboynik, O. Yu., Antypenko, O. M., Berest, G. G., Nosulenko, I. S., Palchikov, V. O., Karpenko, O. V., & Kovalenko, S. I. (2017). Desing, synthesis and anti-inflammatory activity of dirivatives 10-R-3-aryl-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]quinazolin-2-ones of spiro-fused cyclic frameworks. Acta Chimica Slovenica, 64(4), 902-910. https://doi.org/10.17344/acsi.2017.3575

Martynenko Yu. V., Kazunin M. S., Nosulenko I. S., Berest G. G., Kovalenko S. I., Kamyshnyi O. M., & Polishchuk N. M. (2018). 2-([1,2,4]triazolo[1,5-c]quinazoline-2-yl-)alkyl-(alkaryl-, aryl-)-amines and their derivatives. Message 2. The synthesis of (3Н-quinazoline-4-ylidene)hydrazides N-protected aminoacids, using a variety of amine-protecting approaches. Physico-chemical properties and biological activity of the synthesized compounds. Zaporozhye medical journal, 20(3), 413-420. https://doi.org/10.14739/2310-1210. 2018.3.130544

Voskoboynik, O. Yu., Shishkina, S. V., & Kovalenko, S. I. (2018). [1,2,4]Triazino[2,3-с]quinazolines 3. Structure and anticancer activity of products obtained from reaction of 3-(2-aminophenyl)-6-R-1,2,4-triazin-5(2H)-ones with aryl iso(thio)cyanates. Chemistry of Heterocyclic Compounds, 54(7), 717-728. https://doi.org/10.1007/s10593-018-2338-3

Martynenko, Yu. V., Antypenko, O. M., Nosulenko, I. S., Berest, G. G., & Kovalenko, S. I. (2019). Directed search of anti-inflammatory agents among (3H-quinazoline-4-ylidene)hydrazides of N-protected amino acids and their heterocyclization products. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 18(2). 1-12. https://doi.org/10.2174/1871523018666190115092215

Stavitskiy, V. V., Voskoboinik, O. Yu., Nosulenko, I. S., Klimova, O. O., Brazhko, O. A., & Kovalenko, S. I. (2019). Zamisheni 3-R-7,8-digidro-2H-pirolo[1,2-a][1,2,4]triazino[2,3-c]hinazolin-5a(6H)-alkil-karbonovi kysloty - perspektyvnyi klas malotoksychnykh protyzapalnykh ahentiv [Substituted 3-R-7,8-dihydro-2H-pyrrolo[1,2-a][1,2,4]triazino[2,3-c]quinazolin-5a-(6H)-alkyl-carboxylic acids - promising class of low-toxic anti-inflammatory agents] Farmatsevtychnyi chasopys, (3), 5-12. [in Ukrainian]. https://doi.org/10.11603/2312-0967.2019.3.10468

Mashima, R., & Okuyama, T. (2015). The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biology, 6, 297-310. https://doi.org/10.1016/j.redox.2015.08.006

Voskoboinyk, O. Yu., Kovalenko, S. I., Malkova, T. S., & Stavytskyi, V. V. (2018). Pirolo[1,2-a][1,2,4]tryazyno[2,3-c]khinazoliny ta izoindolo[2,1-a][1,2,4]tryazyno[2,3-c]khinazoliny [Pyrrolo [1,2-a] [1,2,4]triazino [2,3-c]quinazolines and isoindolo [2,1-a][1,2,4] triazino [2,3-c] quinazolines]. Ukraine Patent UA 118196. Retrieved from https://base.uipv.org/searchINV/search.php?action=viewdetails&IdClaim=253331 [in Ukrainian].

Worldwide Protein Data Bank. (n.d.). Protein Data Bank (PDB) [Database]. Retrieved from http://www.pdb.org

ChemAxon. (2015). MarvinSketch, Version 6.3.0. [Software]. Retrieved from http://www.chemaxon.com

Trott, O., & Olson, A. J. (2010). Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. Journal of Computational Chemistry, 31(2), 455-461. https://doi.org/10.1002/jcc.21334

Biovia. (2019). Discovery Studio Visualizer, v 19.1.0.18287 [Software]. Retrieved from http://www. 3dsbiovia.com/

Molinspiration Cheminformatics. (n.d.). Calculation of Molecular Properties and Bioactivity Score [Computer software]. Retrieved from http://www.molinspiration.com/cgi-bin/properties

Pontiki, E., & Hadjipavlou-Litina, D. (2007). Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents. Bioorganic & Medicinal Chemistry, 15(17), 5819-5827. https://doi.org/10.1016/j.bmc.2007.06.001

Кorobko, D., Hadjipavlou-Litina, D. J., & Logoyda, L. (2018). Antioxidant and anti-inflammatory properties of a series of new 7,8-disubstituted theophylline containing a pyrazole ring. Asian Journal of Pharmaceutical and Clinical Research, 11(6), 448-450. http://dx.doi.org/10.22159/ajpcr.2018.v11i6.25990

How to Cite

1.
Stavytskyi VV, Nosulenko IS, Portna OO, Shvets VM, Voskoboynik OY, Kоvalenko SІ. Substituted pyrrolo[1,2-a][1,2,4]triazolo-(triazino-)[c]quinazolines - a promising class of lipoxygenase inhibitors. Current issues in pharmacy and medicine: science and practice [Internet]. 2019Nov.21 [cited 2024Apr.14];(3). Available from: http://pharmed.zsmu.edu.ua/article/view/198086

Issue

Section

Original research